Agilent Technologies Inc.'s Stratagene Announces Expanded Line of QPCR, QRT-PCR Reagents at American Association for Cancer Research Conference
Published: Apr 15, 2008
SAN DIEGO--(BUSINESS WIRE)--Stratagene, an Agilent Technologies Inc. (NYSE:A) company, announced today it has launched an expanded line of quantitative PCR reagents with enhanced sensitivity of detection. This new line of Brilliant II QPCR and QRT-PCR reagents was developed specifically to provide improved performance on the Stratagene Mx systems. The launch of Brilliant II is the first major product introduction by Stratagene since Agilent acquired the company in 2007.